HBIO logo

Harvard Bioscience, Inc. (HBIO)

Profile

Full Name

Harvard Bioscience, Inc.

Ticker

NASDAQ: HBIO

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Instruments & Supplies

Country

United States

IPO

March 19, 2001

Indexes

Not included

Website

https://www.harvardbioscience.com

Employees

330

Key Details

Price

$0.74(-0.31%)

Market Cap

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$94.14M(-16.14% YoY)

Annual EPS

-$0.28(-253.91% YoY)

PE Ratio

-

Next earnings date

Mar 12, 2026

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $0.74
    HBIO price is $0.74

    30-Day Relative Volume

    0.24
    HBIO 30-day relative volume is 0.24

    Price Performance

    Price Most Recent Change

    -0.31%
    HBIO price was down -0.31% on Dec 12, 2025

    Price YTD Change

    -64.89%
    HBIO price is down -64.89% since January 1st

    Price 1-Year Change

    -66.92%
    HBIO price is down -66.92% year-on-year

    Price 3-Year Change

    -71.72%
    HBIO price is down -71.72% over the past 3 years

    Price Range

    Price All-Time High

    $10.99
    HBIO price is currently -93.26% below its historical high of $10.99

    Price 3-Year Low

    $0.28
    HBIO price is currently +164.61% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $33.03M
    HBIO market cap is $33.03 million

    Market Cap 3-Year Change

    -69.74%
    HBIO market cap is down -69.74% over the past 3 years

    Market Cap All-Time High

    $345.26M
    HBIO market cap is currently -90.43% below its historical high of $345.26 million

    Market Cap Sector Percentile

    28.91%
    HBIO market cap is higher than 28.91% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +2.21%
    HBIO shares outstanding is up +2.21% year-on-year

    Shares Outstanding 3-Year Change

    +7.01%
    HBIO shares outstanding is up +7.01% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    2.32
    HBIO beta is 2.32

    200-day SMA

    $0.50
    HBIO price is currently +46.77% above its 200-day simple moving average

    50-day SMA

    $0.57
    HBIO price is currently +30.23% above its 50-day simple moving average

    14-Day RSI

    58.72
    HBIO 14-day relative strength index is 58.72

    Volume

    0.24
    HBIO 30-day relative volume is 0.24

    ATR

    $0.07
    HBIO average true range is $0.07

    10-day Historical Volatility

    63.02%
    HBIO 10-day historical volatility is 63.02%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $94.14M
    HBIO annual revenue is $94.14 million

    Revenue Analysts Estimate

    $85.90M
    HBIO annual revenue is currently +9.59% higher than the consensus analysts' forecast

    Revenue 1-Year Change

    -16.14%
    HBIO annual revenue is down -16.14% year-on-year

    Revenue Sector Percentile

    67.97%
    HBIO annual revenue is higher than 67.97% of companies in Healthcare sector

    EPS

    EPS

    -$0.28
    HBIO annual earnings per share is -$0.28

    EPS Analysts Estimate

    $0.03
    HBIO annual earnings per share is currently -1049.67% lower than the consensus analysts' forecast

    EPS 1-Year Change

    -253.91%
    HBIO annual earnings per share is down -253.91% year-on-year

    EPS Sector Percentile

    73.36%
    HBIO annual earnings per share is higher than 73.36% of companies in Healthcare sector

    Profit

    Gross Profit

    $49.55M
    HBIO annual gross profit is $49.55 million

    Gross Margin

    52.64%
    HBIO annual gross profit margin is 52.64%

    Operating Profit

    -$4.56M
    HBIO annual operating income is -$4.56 million

    Operating Margin

    -52.20%
    HBIO annual operating profit margin is -52.20%

    Net Income

    -$12.40M
    HBIO annual net profit is -$12.40 million

    Net Margin

    -13.18%
    HBIO annual net profit margin is -13.18%

    Expenses

    Total Expenses

    $106.54M
    HBIO annual total expenses is $106.54 million

    Operating Expenses

    $54.11M
    HBIO annual total operating expenses is $54.11 million

    Cost Of Goods Sold

    $44.58M
    HBIO annual cost of goods sold is $44.58 million

    Selling, General & Administrative Expenses

    $0.00
    HBIO annual SG&A is $0.00

    Depreciation & Amortization

    $7.16M
    HBIO annual D&A is $7.16 million

    Interest Expense

    $0.00
    HBIO annual interest expense is $0.00

    Income Tax

    $740.00K
    HBIO annual income tax is $740.00 thousand

    EBIT & EBITDA

    EBIT

    -$4.56M
    HBIO annual earnings before interest & taxes is -$4.56 million

    EBITDA

    $2.42M
    HBIO annual EBITDA is $2.42 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $126.64M
    HBIO annual total assets is $126.64 million

    Non Current Assets

    $81.53M
    HBIO annual long term assets is $81.53 million

    Current Assets

    $45.12M
    HBIO annual total current assets is $45.12 million

    Cash and Cash Equivalents

    $4.11M
    HBIO annual cash & cash equivalents is $4.11 million

    Accounts Receivable

    $14.87M
    HBIO annual accounts receivable is $14.87 million

    Inventory

    $23.25M
    HBIO annual inventory is $23.25 million

    Liabilities

    Total Liabilities

    $63.30M
    HBIO annual total liabilities is $63.30 million

    Long Term Liabilities

    $1.97M
    HBIO annual total long term liabilities is $1.97 million

    Current Liabilities

    $54.96M
    HBIO annual current liabilities is $54.96 million

    Accounts Payable

    $4.79M
    HBIO annual accounts payable is $4.79 million

    Debt

    Total Debt

    $44.49M
    HBIO annual total debt is $44.49 million

    Total Debt 1-Year Change

    +4.03%
    HBIO annual total debt is up +4.03% year-on-year

    Long Term Debt

    $6.38M
    HBIO annual long term debt is $6.38 million

    Short Term Debt

    $38.11M
    HBIO annual short term debt is $38.11 million

    Equity & Capital

    Shareholders Equity

    $63.34M
    HBIO annual stockholders equity is $63.34 million

    Book Value

    $63.34M
    HBIO annual book value is $63.34 million

    Retained Earnings

    -$158.01M
    HBIO annual retained earnings is -$158.01 million

    Working Capital

    -$9.84M
    HBIO annual working capital is -$9.84 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    $1.44M
    HBIO annual cash from operations is $1.44 million

    Cash From Operations 1-Year Change

    -89.73%
    HBIO annual cash from operations is down -89.73% year-on-year

    Cash From Investing

    -$1.34M
    HBIO annual cash from investing is -$1.34 million

    Cash From Investing 1-Year Change

    +25.29%
    HBIO annual cash from investing is up +25.29% year-on-year

    Cash From Financing

    -$131.00K
    HBIO annual cash from financing is -$131.00 thousand

    Cash From Financing 1-Year Change

    +98.92%
    HBIO annual cash from financing is up +98.92% year-on-year

    CAPEX

    CAPEX

    $3.26M
    HBIO annual capital expenditures is $3.26 million

    CAPEX 1-Year Change

    +41.19%
    HBIO annual capital expenditures is up +41.19% year-on-year

    Free Cash Flow

    Free Cash Flow

    -$1.82M
    HBIO annual free cash flow is -$1.82 million

    Free Cash Flow 1-Year Change

    -115.56%
    HBIO annual free cash flow is down -115.56% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    52.64%
    HBIO annual gross profit margin is 52.64%

    Operating Margin

    -52.20%
    HBIO annual operating profit margin is -52.20%

    Net Margin

    -13.18%
    HBIO annual net profit margin is -13.18%

    ROA & ROE

    ROA

    -9.40%
    HBIO annual return on assets is -9.40%

    ROE

    -18.19%
    HBIO annual return on equity is -18.19%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    HBIO price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    HBIO price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    2.35
    HBIO price to book ratio is 2.35

    PB Ratio Sector Percentile

    54.42%
    HBIO price to book ratio is higher than 54.42% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    0.38
    HBIO price to sales ratio is 0.38

    PS Ratio Sector Percentile

    10.77%
    HBIO price to sales ratio is higher than 10.77% of companies in Healthcare sector

    Enterprise value

    Enterprise Value

    $69.00M
    HBIO enterprise value is $69.00 million

    Enterprise Value Sector Percentile

    39.24%
    HBIO enterprise value is higher than 39.24% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    14.78
    HBIO EV/EBITDA is 14.78

    EV/EBITDA Sector Percentile

    86.66%
    HBIO EV/EBITDA is higher than 86.66% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    0.82
    HBIO annual current ratio is 0.82

    Quick Ratio

    0.40
    HBIO annual quick ratio is 0.40

    Leverage

    Debt To Equity

    0.70
    HBIO annual debt to equity ratio is 0.70

    Interest Coverage Ratio

    -
    HBIO annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    5
    HBIO piotroski f-score is 5

    Altman Z-Score

    -0.90
    HBIO altman z-score is -0.90

    Analyst ratings

    Recent major analysts updates

    Sep 10, 25 Benchmark
    Speculative Buy
    May 13, 25 Benchmark
    Speculative Buy
    Apr 9, 25 Keybanc
    Sector Weight
    Apr 8, 25 Keybanc
    Sector Weight
    Mar 24, 25 Benchmark
    Speculative Buy
    Jun 22, 23 Benchmark
    Speculative Buy
    Apr 26, 23 Keybanc
    Overweight
    Apr 26, 23 Benchmark
    Buy
    Mar 10, 23 Benchmark
    Buy
    Nov 9, 22 Keybanc
    Overweight

    Institutional Ownership

    Screeners with HBIO included

    Growing Shares Outstanding
    Stocks cheaper than 1 dollar
    US stocks
    Stocks with high beta
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    • What is the ticker symbol for Harvard Bioscience, Inc.?
    • Does Harvard Bioscience, Inc. pay dividends?
    • What sector is Harvard Bioscience, Inc. in?
    • What industry is Harvard Bioscience, Inc. in?
    • What country is Harvard Bioscience, Inc. based in?
    • When did Harvard Bioscience, Inc. go public?
    • Is Harvard Bioscience, Inc. in the S&P 500?
    • Is Harvard Bioscience, Inc. in the NASDAQ 100?
    • Is Harvard Bioscience, Inc. in the Dow Jones?
    • When was Harvard Bioscience, Inc.'s last earnings report?
    • When does Harvard Bioscience, Inc. report earnings?

    What is the ticker symbol for Harvard Bioscience, Inc.?

    The ticker symbol for Harvard Bioscience, Inc. is NASDAQ:HBIO

    Does Harvard Bioscience, Inc. pay dividends?

    No, Harvard Bioscience, Inc. does not pay dividends

    What sector is Harvard Bioscience, Inc. in?

    Harvard Bioscience, Inc. is in the Healthcare sector

    What industry is Harvard Bioscience, Inc. in?

    Harvard Bioscience, Inc. is in the Medical Instruments & Supplies industry

    What country is Harvard Bioscience, Inc. based in?

    Harvard Bioscience, Inc. is headquartered in United States

    When did Harvard Bioscience, Inc. go public?

    Harvard Bioscience, Inc.'s initial public offering (IPO) was on March 19, 2001

    Is Harvard Bioscience, Inc. in the S&P 500?

    No, Harvard Bioscience, Inc. is not included in the S&P 500 index

    Is Harvard Bioscience, Inc. in the NASDAQ 100?

    No, Harvard Bioscience, Inc. is not included in the NASDAQ 100 index

    Is Harvard Bioscience, Inc. in the Dow Jones?

    No, Harvard Bioscience, Inc. is not included in the Dow Jones index

    When was Harvard Bioscience, Inc.'s last earnings report?

    Harvard Bioscience, Inc.'s most recent earnings report was on November 6, 2025

    When does Harvard Bioscience, Inc. report earnings?

    The next expected earnings date for Harvard Bioscience, Inc. is March 12, 2026
    On this page